Delivery Order SPE2DB20D1109-SPE2DB24FN09D

Award Date 11/16/23
Potential Completion Date 11/17/23
Potential Value $21K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Jardiance 10 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $6,134.12 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award is for the delivery of Jardiance 10 mg tablets to the Defense Logistics Agency (DLA). The $19,932.58 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of December 27, 2023 and was awarded on December 26, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The $19,736.17 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of September 28, 2023 and was awarded on September 27, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $12,841.94, was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. This is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. The IDC, which runs through November 2026, enables the efficient procurement of a...
This federal contract award, valued at $52,538.05, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of July 26, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor...
This federal contract award is for the delivery of Jardiance 10 mg tablets to the Defense Logistics Agency (DLA). The prime contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The contract award, valued at $21,654.46, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
This federal contract award is for the supply of Jardiance 10 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $25,690.57, with a firm fixed price. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $43,434.93 and an ultimate completion date of February 23, 2024. This is a delivery order contract with a firm fixed-price pricing type, and it was not set aside for any specific business category. Amerisourcebergen...
This federal contract award is for the delivery of Jardiance 10 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $17,418.55, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 6, 2024. The contract has a completion date of November 7, 2024 and is a firm fixed-price delivery order. There is no set-aside designation indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $4,034.18 and an Ultimate Completion Date of February 12, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FN09D
    Delivery Order

This federal contract award is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for $21,487.89. The contract has an ultimate completion date of November 17, 2023 and is a firm fixed-price delivery order. There is no set-aside designation for this award.

Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 5/12/25, 10:47 AM